Transforming growth factor .alpha.H1
US5633147A · kind A · utility
33Cited by
2References
36Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 8, 1994 |
| Grant date | May 27, 1997 |
| Priority date | — |
| Expiry date | Mar 8, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/026
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a human TGF.alpha.-H1 polypeptide and DNA (RNA) encoding such TGF.alpha.-H1 polypeptides. Also provided is a procedure for producing such polypeptide by recombinant techniques and for producing antibodies and antagonists against such polypeptide. Such polypeptides may be combined with a suitable pharmaceutical carrier or diluent to provide diagnostic, therapeutic and/or prophylactic effects against various diseases. Also provided, are methods of using the antibodies and antagonists to inhibit TGF.alpha.-H1 for therapeutic purposes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.